The molecular mechanism of striking higher prevalence of hepatocellular carcinoma (HCC) in male subjects has not yet been fully elucidated. Here, we report that androgen receptor (AR) is differentially expressed in different HCC cell lines. AR agonist dihydrotestosterone (DHT) enhances HCC cell growth and apoptotic resistance. Antagonist flutamide (FLU) blocks the effects of DHT on the HCC cell lines. Paternally expressed gene 10 (PEG10) is expressed in HCC cell lines at substantial high level. Using small interfering RNAs against AR and PEG10 in AR-and PEG10-expressing BEL-7404 hepatoma cells and HuH7 hepatoma cells (HuH7) cells, and AR-transfection technique in AR-lacking and PEG10-expressing HepG2 cells, we have confirmed that through upregulation and activation of PEG10, DHT enhances HCC cell growth and apoptotic resistance. We have further demonstrated that DHT upregulates expression of human telomerase reverse transcriptase (hTERT) in HCC cell lines in a PEG10-dependent manner. Moreover, AR directly interacts in vivo with androgen-responsive elements in the regions of promoter and exon 2 of PEG10 gene in HCC cell lines. DHT promotes the hepatoma formation in vivo nude mice through PEG10 activation. AR antagonists (FLU and valproate) inhibit the hepatoma formation. These findings suggest that PEG10 plays an essential role in hepatocarcinogenesis. The PEG10 inhibition can be a novel approach for therapy of HCC. Oncogene (2007) 
The molecular mechanism of striking higher prevalence of hepatocellular carcinoma (HCC) in male subjects has not yet been fully elucidated. Here, we report that androgen receptor (AR) is differentially expressed in different HCC cell lines. AR agonist dihydrotestosterone (DHT) enhances HCC cell growth and apoptotic resistance. Antagonist flutamide (FLU) blocks the effects of DHT on the HCC cell lines. Paternally expressed gene 10 (PEG10) is expressed in HCC cell lines at substantial high level. Using small interfering RNAs against AR and PEG10 in AR-and PEG10-expressing BEL-7404 hepatoma cells and HuH7 hepatoma cells (HuH7) cells, and AR-transfection technique in AR-lacking and PEG10-expressing HepG2 cells, we have confirmed that through upregulation and activation of PEG10, DHT enhances HCC cell growth and apoptotic resistance. We have further demonstrated that DHT upregulates expression of human telomerase reverse transcriptase (hTERT) in HCC cell lines in a PEG10-dependent manner. Moreover, AR directly interacts in vivo with androgen-responsive elements in the regions of promoter and exon 2 of PEG10 gene in HCC cell lines. DHT promotes the hepatoma formation in vivo nude mice through PEG10 activation.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common malignancy with a striking higher prevalence in men subjects than in women subjects throughout the world (Yu et al., 2001) . Endocrinological and epidemiological studies indicate that HCC has a significantly higher concentration of androgen receptor (AR) than the surrounding liver tissue (Nagasue et al., 1995) , and is an androgen-dependent tumor. However, the molecular mechanisms underlying the cellular regulation of AR expression in these cells still remain to be fully investigated.
Paternally expressed gene 10 (PEG10) is newly identified as a paternally expressed gene at human chromosome 7q21 (Ono et al., 2001) , functioning as a transcriptional factor (Steplewski et al., 1998 ). An elevated PEG10 expression in the majority of the human HCC cells and G2/M phase of regenerating mouse liver are indicating that this gene has growth-promoting activity (Okabe et al., 2001; Tsou et al., 2003) . The imbalance between expression of PEG10 and SIAH1, a mediator of apoptosis, may be involved in hepatocarcinogenesis through inhibition of apoptosis (Okabe et al., 2003; Tsou et al., 2003) . PEG10 is also overexpressed in the embryonic form of biliary atresia, a disease associated with cell proliferation (Zhang et al., 2004) . PEG10 À/À mice show early embryonic lethality owing to defects in the placenta, indicating a critical role for mouse parthenogenetic development (Ono et al., 2006) . PEG10 knockdown inhibits the proliferation of pancreatic carcinoma and HepG2 HCC cells . Being activated by CCR7 and CXCR5, overexpressed PEG10 is involved in apoptotic resistance in B-acute lymphoblastic leukaemia CD23 þ CD5 þ B cells (Chunsong et al., 2006) .
The human telomerase reverse transcriptase (hTERT) is the key regulator of telomerase activity. Activation of telomerase enzyme and telomere stabilization is an important step in carcinogenesis (Greider, 1999) . A high telomerase activity can be detected in HCC (Komine et al., 2000; Youssef et al., 2001) . A connection between telomerase activity and resistance to apoptosis has been reported (Ramirez et al., 2003) . Telomerase inhibiting and telomere shortening trigger apoptotic death in various cell types (Greider, 1999) . Telomerase has therefore been proposed as a marker for carcinogenesis.
Results

Differential expression of AR in HCC cell lines
Real-time quantitative reverse transcriptase-polymerase chain reaction (QRT-PCR) assay data for messenger ribonucleic acid (mRNA) revealed that AR was rarely expressed in normal hepatocytes. It was expressed in BEL-7404 hepatoma cells (BEL) cells at substantial high level, in HuH7 hepatoma cells (HuH7) cells at moderate level, and in HepG2 cells at very low level ( Figure 1a) . The data by Northern and Western blotting assays confirmed the observation (Figure 1b) .
Effects of DHT on HCC cell lines
We next examined effects of AR agonist dihydrotestosterone (DHT) on cell growth, apoptosis and PEG10 expression in different HCC cells. There was no statistically significant proliferation of normal hepatocytes in culture without or with DHT ( Figure 2a ). There were no statistical differences on cell numbers of tested three HCC cell lines in culture without DHT (Figure 2a ). The growth rates of BEL cells and HuH7 cells in culture with DHT were significantly increased in comparison with that of the normal hepatocytes and HepG2 cells (Figure 2a ). AR antagonist flutamide (FLU) completely blocked the effects of DHT on the cell growth (Figure 2a ). The number of apoptotic cells after 5-FU treatment was significantly decreased in culture of BEL cells and HuH7 cells in the presence of DHT in comparison with that of the normal hepatocytes and HepG2 cells, whereas, there were no statistical differences on cell numbers of the tested three HCC cell lines in culture without DHT (Figure 2b and c) . FLU completely blocked the effects of DHT on the cell apoptosis. FLU alone in culture did not affect either on cell growth or on resistance to apoptosis in normal hepatocytes and different HCC cell lines (data not shown).
To determine whether PEG10 was responsible for cell growth and resistance to apoptosis induced by stimulation with DHT, the cells were pretreated without or with DHT or/and FLU before further assays. PEG10 was expressed in tested three HCC cell lines at high level and in normal hepatocytes at rather low level (Figure 3a) . DHT or/and FLU did not alter PEG10 expression in low-AR-expressing HepG2 cells (Figure 3b ). However, PEG10 expressions were significantly increased in the HuH7 cells and BEL cells in culture with DHT in comparison with that in the normal hepatocytes and HepG2 cells (Figure 3c Necessity of PEG10 to DHT-induced HCC cell growth and apoptotic resistance To further confirm roles of AR and PEG10 in DHTinduced HCC cell growth and apoptotic resistance, we chose the high AR-and PEG10-expressing BEL cells as investigating target cells. We first applied small interfering RNA (siRNAAR) to knockdown AR expression in the cells. The siRNAAR at high concentration (2 mg/ml) sequence specifically abolished AR expression in BEL cells (Figure 4a ). The siRNAAR (2 mg/ml) partially knocked down PEG10 expression in BEL cells In upper panels of (b), mRNA of AR in NML, HepG2, HuH7 and BEL cells were detected by Northern blot. The hybridization signals for AR mRNA from different cells were shown in upper images. The 28S rRNAs in lower images confirmed that comparable amounts of total RNA were used. In lower panels of (b), the AR protein was examined using Western blot analysis. Actins in lower images indicated the quantity of total cellular protein from the tested samples loaded in each lane. Arrows indicated markers used to verify equivalent molecular weights of appropriate proteins in each lane.
Hepatocarcinogenesis and PEG10 activation X Jie et al Figure 2 DHT enhances cell growth and reduces apoptosis in AR-expressing HCC cell lines. Cell growth (a), apoptosis (b) and total dead cells (necrotic and apoptotic) (c) of normal hepatocytes and different HCC lines were examined. The cells were treated without (white bars) or with DHT (100 nM) (black bars) or with FLU þ DHT (gray bars) before assays. In (a), equal numbers (2 Â 10 4 ) of cells with different treatment were plated in complete media and viable cell numbers were determined at 5 days later. Each test was triplicate in three wells. Each bar represents mean values7s.d. of eight experiments. Statistically significant differences were indicated as compared with NML (**Po0.001, untreated versus treated with DHT or with FLU þ DHT). In (b), The cells were treated without or with DHT or with FLU þ DHT before assays. The 5-fluorouracil (1 mM) was added directly into the medium to induce apoptosis. The cells treated without 5-FU were used as negative control (Untreated). After 72 h, the cells were analyzed by flow cytometry for PI (y axis) and FITC-conjugated annexin V (x axis). The percentages of PI À annexin V þ cells and PI þ annexin V þ cells were indicated in the figure. The data were from representatives of eight experiments performed. In (c), the cells were treated without (black bars) or with DHT (100 nM) (brick format bars) or with FLU þ DHT (gray bars). The cells treated without 5-FU were used as negative control (white bars). The data for total dead cells (PI
were mean values7s.d. of eight experiments performed. Statistically significant differences as compared with controls were indicated (**Po0.001, untreated versus treated with DHT or with FLU þ DHT).
( Figure 4b ), indicating that PEG10 expression was closely associating with AR expression. Functionally, the siRNAAR (2 mg/ml) significantly and sequence specifically blocked the ability of DHT to enhance cell growth and apoptotic resistance in BEL cells (Figure 4c and d). Additionally, we had observed a similar effect of siRNAAR in AR-expressing and PEG10-expressing HuH7 cells (data not shown). The 27-mer-siRNAAR (Kim et al., 2005) The siRNAPEG10 at high concentration (2 mg/ml) sequence-specifically and completely abolished expression of PEG10 in BEL cells at mRNA and protein levels ( Figure 5a ). Functionally, the siRNAPEG10 (2 mg/ml) sequence-specifically blocked the ability of DHT to enhance cell growth and apoptotic resistance in BEL cells (Figure 5b and c). We had also observed a similar effect of siRNAPEG10 in AR-expressing and PEG10-expressing HuH7 cells (data not shown).
We chose the low-AR-expressing and high PEG10-expressing HepG2 cells as investigating target cells to transfect additional AR. The cells were successfully transfected with AR-encoding plasmid and the expression level of AR was increased significantly, especially in the cells that a higher dose of AR-encoding plasmid was applied (600 ng) (Figure 6a and b). PEG10 expression, however, was not altered in the cells. HepG2 cells grew significantly faster after a successful AR-transfection at high dose in the presence of DHT (Figure 6c ). The number of apoptotic cells was significantly decreased after a successful AR-transfection within a dose-dependent manner in the presence of DHT ( Figure 6d ). Generally, DHT could promote cell growth and apoptotic resistance in HCC cells, but had no effect on AR-or PEG10-downknocked cells.
Effect of DHT on hTERT expression in HCC cells is PEG10-dependent
To further explore the mechanisms of DHT effects on HCC cells, the chosen BEL cells were first cultured without or with siRNAPEG10, and then treated without or with DHT. The expression level of hTERT was significantly increased when the cells were treated with DHT ( Figure 7a ). However, when BEL cells were pretreated with siRNAPEG10, the expression levels of hTERT were not altered even in the presence of DHT (Figure 7b ). FLU completely blocked the effects of DHT on the upregulation of hTERT expression ( Figure  7a and b). FLU alone in culture did not affect on hTERT expression in normal hepatocytes (data not shown) and BEL cells without or with PEG10-downknocking (Figure 7a and b). Additionally, we had also observed a similar effect of siRNAPEG10 on hTERT expression in HuH7 cells (data not shown). The similar effects of DHT on hTERT expression were also demonstrated in HEK293T cells cotransfected with AR-and PEG10-encoding plasmids (600 ng each) (Figure 7c ). In HEK293T cells transfected with only AR, we observed that hTERT expression was constant at low level no matter whether the cells were treated with DHT ( Figure 7d ). and d) , different HCC cell lines as indicated were treated without, or with DHT (100 nM) or with FLU þ DHT and then subjected to further assays (Q-PCR, upper panels; Northern blot, middle panels; Western blot, lower panels, respectively). Statistically significant differences were indicated (*Po0.05, **Po0.001, normal hepatocytes versus HCCs, or untreated versus treated). The data were mean values7s.d. of eight experiments in each group.
AR binds to PEG10 in vivo
In order to further explore the mechanisms of DHT effects on HCC cells, we applied chromatin immunoprecipitation (ChIP) assay to examine whether DHT could activate AR directly to bind to PEG10 and its promoter region. We searched for androgen response elements (AREs) in the PEG10 gene (Rokhlin et al., 2005) . Several AREs had been found in intron and exon regions as well as in promoter region. Four primer sets were designed to cover the found PEG10-AREs. After the cells were stimulated with DHT, AR interacted in vivo with the ARE in exon 2 and promoter region, but not in intron in the PEG10 gene (Figure 8a and b) , indicating a direct regulation of PEG10 expression. We co-transfected a PEG10/luciferase reporter with AR expression vector into HEK293T cells, which originally , Northern blot (middle panels) and Western blot (lower panels). The siRNAAR was transfected with appropriate concentration following the manufacturer's instructions. Control, negative control siRNA with irrelevant sequence (2 mg/ml); siRNAARl, low concentration (0.02 mg/ml); siRNAARh, high concentration (2 mg/ml). The data were mean values7s.d. of eight experiments in each group. The images were representatives of eight experiments performed in each group. Cell growth (c) and apoptosis (d) were examined after treatment with DHT (100 nM). In (c), BEL cells were transfected with vector ('), negative control siRNA (&), siRNAARl () and siRNAARh (J) before assays. The total cell numbers were measured to assess the effect of steroid DHT on cell growth by day 5. Each test was triplicate in three wells. Each line represents mean values7s.d. of eight experiments. Statistically significant differences were indicated (*Po0.05, **Po0.001, control versus siRNA treated). In (d), BEL cells were untransfected (Untrans.) or transfected with vector, negative control siRNA (Control), siRNAARl and siRNAARh as indicated before assays. (E), untransfected cells were treated without DHT (100 nM). (J), siRNAAR-transfected cells were treated without DHT. The 5-fluorouracil (1 mM) was added directly into the medium to induce apoptosis. The data were representatives of eight experiments performed. In (e), BEL cells were transfected with vector (white bars), negative control 27-mer-siRNA (black bars) and 27-mer-siRNAAR (2 mg, gray bars) before assays. The expression level of AR and PEG10 were examined by Q-PCR (upper left panel). The total cell numbers were measured to assess the effect of steroid DHT on cell growth in 5 days (lower panel). Cells were transfected with vector ('), negative control 27-mer-siRNA (&) and 27-mer-siRNAAR (J) before assays. After pretreatment with DHT (100 nM), the 5-fluorouracil (1 mM) was added directly into the medium to induce apoptosis (upper right panel). BEL cells were transfected with vector (white bars), negative control 27-mer-siRNA (black bars) and 27-mer-siRNAAR (2 mg/ml, gray bars) before assays. The data were mean values7s.d. of six experiments performed. Statistically significant differences were indicated (**Po0.001, vector versus 27-mer siRNA treated).
expressed neither AR nor PEG10. The co-transfected HEK293T cells were treated with 100 nM DHT for 24 h before harvest for luciferase assays. PEG10 promoter activity was significantly increased in DHT-treated cells in comparison with the cells treated without the hormone (Figure 8c ).
Hepatoma formation of HCC cells in vivo nude mice
To test whether there were effects of AR agonist and antagonist, siRNAAR and siRNAPEG10 on the carcinogenicity of HCC cells in vivo, differentially treated HepG2 and BEL cells were subcutaneously injected into nude mice, and tumor growth was monitored. Showing in Table 1 , at the end of the study (day 40), tumors had developed at all sites injected with different HCC cells. However, the average tumor volumes for the original and differentially treated HepG2 and BEL cells were significantly different. Generally, DHT treatment could promote hepatoma formation, especially where high AR-expressing BEL cells were injected. The tumor growth was faster where AR-transfected HepG2 cells were injected in the presence of DHT. The hepatoma formation was decreased where siRNAPEG10-treated HepG2 or BEL cells were injected even in the presence of DHT. Pretreatment with AR antagonist FLU (interestingly also with valproate (VPA)) significantly slowed down hepatoma formation in nude mice.
Discussion
Primary HCC represents the fifth leading cancer and the third most common cause of death from cancer worldwide. HCC is more prevalent in men subjects than it is in female subjects (Yu et al., 2001) . The carcinogenesis of original HepG2 cells and BEL cells are significantly different in vitro and in vivo (Figure 2 and Table 1) because of differential AR expression on the cells (Figure 1) . Our consistent evidences have demonstrated that DHT exposure and AR expression level are responsible for the androgen-related enhancement of HCC carcinogenesis.
Distinct expression of PEG10 is found in the brain, kidney, lung, testis and placenta but not in the liver and a number of other tissues (Ono et al., 2001; Okabe et al., 2003) . PEG10 is expressed in three HCC cell lines at high level (Figure 3) . The expression level of PEG10 can be downregulated as AR expression is reduced by siRNAAR (Figure 4 ). PEG10 expression is elevated in the AR-expressing HCC cells by culture with DHT in comparison with that in the low AR-expressing HCC cells (Figure 3) . The siRNAPEG10 blocks the ability of DHT to enhance cell growth and apoptotic resistance in HCC cells in vitro ( Figure 5 ) and hepatoma formation of HCC cells in vivo (Table 1) . This is the first time that PEG10 has been found to directly interact with DHT/ AR increasing HCC cell malignancy. Understanding the molecular basis of abnormal imprinting of PEG10 in human HCC will shed new light into the process and mechanism to develop malignant liver disorders.
Telomerase has been proposed as an important marker for carcinogenesis and is a potentially highly selective target for the development of antiproliferative agents and anti-tumor drugs (Shammas et al., 2005) . Expression of hTERT is increased when PEG10 expressing HCC cells are treated with DHT. The hTERT expression is downregulated as PEG10 is downknocked by siRNAPEG10, and upregulated as and Western blot (right, lower panels). The siRNAPEG10 was transfected with appropriate concentration following the manufacturer's instructions. Control, negative control siRNA with irrelevant sequence (2 mg/ml); siRNAPEG10l, low concentration (0.02 mg/ml); siRNAPEG10h, high concentration (2 mg/ml). The data were mean values7s.d. of eight experiments in each group. The images were representatives of eight experiments performed in each group. Cell growth (b) and apoptosis (c) were examined after treatment with DHT (100 nM). In (b), BEL cells were transfected with vector (white bars), negative control siRNA (black bars), siRNAPEG10l (brick form bars) and siRNAPEG10h (gray bars) before assays. The total cell numbers were measured to assess the effect of steroid DHT on cell growth 5 days later. Each test was triplicate in three wells. Each line represents mean values7s.d. of eight experiments. In (c), BEL cells were untransfected or transfected with vector (white bars), negative control siRNA (black bars), siRNAPEG10l (brick form bars) and siRNAPEG10h (gray bars) before assays. The 5-fluorouracil (1 mM) was added directly into the medium to induce apoptosis. The data were representatives of eight experiments performed. The data were mean values7s.d. of eight experiments in each group. Statistically significant differences were indicated (*Po0.05, **Po0.001, control versus siRNA treated).
Hepatocarcinogenesis and PEG10 activation X Jie et al PEG10 is transfected into the low PEG10-expressing HEK293T cells in the presence of DHT (Figure 7) . The results strongly suggest that the effect of DHT on hTERT expression in HCC cells is PEG10-dependent, which may partially explain the effect of PEG10 in cell growth promotion, apoptotic resistance and hepatoma formation. VPA, an anticonvulsant drug, has been recently found as a non-steroidal antagonist for human AR (Death et al., 2005) . Pretreatment with VPA significantly slows down hepatoma formation in nude mice. This clue indicates that androgen antagonism of VPA seems likely to contribute to a new therapeutic usage in patients with HCC, particularly, in the patients complicated with endocrine disturbances.
Materials and methods
Cell cultures and reagents
The BEL-7404 human hepatoma cells (from the cell bank of the Institute of Biochemistry and Cell Biology, SIBS, Shanghai, China. Huang et al., 2003) , HuH7 human hepatoma cells, HepG2 human hepatoma cells and HEK293T cells (ATCC, Rockville, MD, USA) were grown in monolayers and cultured in Dulbecco's modified Eagle's medium (DMEM), high glucose (Gibco, Carlsbad, CA, USA). Normal primary human hepatocytes were anonymously from the patients without hepatic disease background undergoing partial liver resection for accidental abdomen trauma. AR agonist dihydrotestosterone (DHT, at 100 nM concentration unless indicated otherwise), AR antagonist FLU and VPA were obtained from Sigma-Aldrich (Saint Louis, MO, USA).
Real-time quantitative RT-PCR assay (Q-PCR)
Q-PCR reactions were performed as described elsewhere (Jinquan et al., 2003) . Q-PCR was performed with an ABI PRISM 7700 Sequence Detector Systems (Applied Biosystems, Foster City, CA, USA). By using SYBR Green reagent, fluorescence signals were generated during each PCR cycle to provide Q-PCR information. The data were expressed as relative mRNA (gene) copies in 25 ng complementary DNA, which was normalized with the expression of a target gene to a housekeeping gene glyceraldehyde-3-phosphate dehydrogenase.
The sequences of the specific primers were as follows: Northern blot analysis For mRNA detection, 2 mg of total RNA obtained from each sample were electrophoresed on 1% agarose formaldehyde gel, followed by blotting onto Nytran membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK), and were crosslinked by UV irradiation as described previously (Sica et al., 1997) . PEG10 ORF coding sequence was obtained by PCR amplification of total RNA from BEL cell. Radiolabeled probes were made by a random priming reaction with [a-32 P]dATP. The RNA blots were prehybridized 1 h and hybridization overnight in a rotating incubator at 681C with PerfectHyb hybridization solution (TOYOBO). Then wash the membrane intensively before being scanned using a PhosphorImager (Storm860, Amersham Bioscience Company, USA).
Western blot analysis
Western blot analysis was contacted as what described previously (Massari et al., 2000) . Briefly, the rabbit antihuman polyclonal to AR was purchased from Abcam Inc.
(Cambridge, UK). The rabbit anti-human polyclonal antibody to PEG10 was raised in our lab and purified from sera of immunized rabbits with recombinant PEG10-his tag protein produced in Escherichia coli. Cell extracts were prepared using sodium dodecyl sulfate (SDS) loading buffer. Proteins were separated by 12% SDS-polyacrylamide gel electrophoresis gel and transferred to Polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% non-fat milk tris buffered saline/Tween-20 and incubated with the antibody. Goat peroxidase-conjugated affinity purified anti-rabbit IgG (Rockland, Gilbertsville, PA, USA) served as the secondary antibody for the SuperSignal West Pico Trial Kit Detection System (Pierce, Rockford, IL, USA). Actin served as an internal control.
Cell growth assays
Cell growth measurement in complete media was performed using a hemocytometer (Zhang et al., 2005) . To assess the effect of steroid DHT on cell growth, cells (2 Â 10 4 ) were plated in 12-well plates in the presence of 100 nM DHT (unless indicated otherwise). The antagonist FLU (1 mM) or VPA (100 mM) was added in blockage experiments. After 24 h, the medium was replaced with steroid DHT medium for 48 h. After 48 h, cells were re-fed with fresh steroid-reduced medium and total cell numbers were assessed 5 days (or indicated days) later.
Flow cytometry
For detection of apoptosis, cells were seeded on six-well plates in steroid-free medium and transfected as described above. After 24 h, the medium was replaced without or with DHT or with FLU þ DHT medium for 48 h. After 24 h of gene transfection, 5-fluorouracil was directly added into the medium to induce apoptosis. The cells were collected after 72 h and washed by cold phosphate-buffered saline twice, followed by stain in staining buffer with 1 mg/ml propidium iodide (PI) for 30 min at 41C, then stained with fluorescein isothiocyanate-conjugated annexin V with binding buffer (BD Pharmingen, San Diego, CA, USA) as described previously (Jinquan et al., 2003) . COULTER XL (Coulter, Miami, FL, USA) was used for analyses.
siRNA gene knockdown assay Sense and antisense strands of siRNA oligonucleotides were designed and synthesized by the State Key Laboratory of Molecular Biology (the Institute of Biochemistry and Cell Biology, SIBS, CAS). PsiRNA-hH1neo (InvivoGen, San Diego, USA) was used to get the sequence of a siRNA duplex. The insert was cloned downstream of human H1 promoter. The siRNAs against AR and PEG10 were named siRNAAR, siRNAPEG10, respectively. A 27-mer siRNA against AR were designed (Kim et al., 2005) in the additional experiments.
The sequences of siRNAs were as follows: The siRNAs were diluted with Opti-MEM I (Invitrogen, Carlsbad, CA, USA) to appropriate concentration. Cells were cultured with serum free and the complexes of siRNAs with the Lipofectamine2000 were transfected for 48 h.
AR and PEG10 transfection
Human AR expression plasmid (pSVhAR) was cloned into pCDNA3.0 (Invitrogen) downstream of a cytomegalovirus immediate early promoter (Lu et al., 2001; Sathya et al., 2003) . Plasmids encoding PEG10 used in this study have been described previously (Tsou et al., 2003) . The cells were transiently transfected with vectors (pCDNA3.0) encoding target genes as described elsewhere (Lu et al., 2001; Sathya et al., 2003; Tsou et al., 2003) . Cells were cultured with serum free and the complexes were transfected, then supplemented with 10% FCS 6 h post-transfection, then incubated at 371C in air containing 5% CO 2 for 48 h. The stable transfection were performed using 8 ml of Lipofectamine2000 and 15 mg of pEGFP-target gene was constructed by inserting a cDNA into the XhoI and EcoRI site of pEGFP-C1) or 15 mg of pEGFP empty vector. To produce stable transfectants, the cells were then split at ratios of 1:20 and cultured for 2 weeks in the presence of 400 mg/ml of G418 (Geneticin sulfate, GIBCO).
ChIP assay
The ChIP assays were performed essentially as described previously (Rokhlin et al., 2005) but with some modifications. Briefly, a total 1 Â 10 7 BEL-7404 cells were cultured without or with DHT for 24 h, crosslinked then with 1% formaldehyde Figure 8 The PEG10 contains AREs and binds to the AR in vivo. The ChIP assay was analyzed by conventional PCR (a) and Q-PCR (b). BEL cells were cultured without (DHT À ) or with DHT (100 nM, DHT þ ). PCR was performed in the presence of [a-32 P]-dATP, using primers for AREs. Input, positive control with non-complex DNA before immunoprecipitation; Mock, dialysis buffer instead of chromatin; AbÀ, control immunoprecipitation procedure without antibodies; Ab þ , chromatin DNA immuno-complexed with AR antibody; Abi, ChIP with mouse IgG. The data shown were representative of three independent experiments. In (c), effect of DHT on PEG10 gene promoter activity. HEK293T cells were cotransfected with the PEG10/luciferase reporter (1 mg) and AR expression vector (600 ng). At 24 h after transfection, cells were cultured without (DHT À ) or with DHT (100 nM, DHT þ ) for further 24 h. The cells were then lysed, and the activities of luciferase were assayed. Vector, empty GL3 basic vector; pLUC-ARE, pGL3 basic vector inserted PEG10 promoter sequence; pGL3-pos, Promega pGL3 positive control vector. Fold change was calculated by comparing the normalized luciferase activity from PEG10-transfected cells with that from vector-transfected cells. The means and s.d. from three independent experiments were shown. The normalized luciferase activity from the cells transfected with the vector was set as 1.0.
for 15 min at room temperature. By using a ChIP Assay Kit (Upstate), cell DNAs were sonicated to an average size of 500 bp by an ultrasonic cell disruptor. Immunoprecipitation was performed overnight at 41C with an anti-AR (C-19; Santa Cruz, Santa Cruz, CA, USA). Precipitates were washed and samples were extracted twice with elution buffer, heated at 651C to reverse crosslinks and DNA fragments were purified with phenol/chloroform. A 5-ml aliquot was used in the PCR. Four primers sets were designed to cover AREs in promoter, intron and exon regions of androgen-responsive gene (PEG10), respectively. ARE sequences were searched using nGnnCnnnnnGnn (in promoter region), or nGnn CnnnnnGnnCn (in intron and exon regions, Rokhlin et al., 2005) as consensus DNA sequences. The chosen primers for AREs were as follows.
Primer set for ARE1 (in promoter region, product: 190 bp): 
PEG10/luciferase reporter constructs and transient transfection assay
Site-directed mutagenesis of the PEG10/luciferase reporter was constructed with synthetic oligonucleotide primers using the pGL3 basic vector (Promega, Madison, WI, USA). The oligonucleotide primers were sense: 5 0 -GGTAC^CACTTC GGTTGGTGTGTGTCG-3 0 , kpnI; antisense: 5 0 -C^TCGAG AAAGCATGGCACTTGGTAGC-3 0 , XhoI. HEK293T cells were seeded at a density of 2 Â 10 5 /well in a six-well dish and grown to 60-70% confluence. A PEG10/luciferase reporter was cotransfected with AR expression vectors using pCDNA3.0 (Invitrogen). Luciferase activities were determined using a Luciferase Reporter Assay System in an Analytical Luminometer Monolight 2010 (PharMingen). The pGL3 control vector was used as a positive control (Promega). Luciferase activities were calculated as the ratio of luciferase activity/protein concentration.
Nude mice hepatoma formation HCC tumors were produced in nude mice (CBy. Cg-Foxn1nu, Jackson Laboratory) and maintained in animal facility in Institute of Biochemistry and Cell Biology, SIBS, CAS (Shanghai, China) in the specific pathogen-free condition. Different human hepatoma cells were subcutaneously injected at left thigh of mice (5 Â 10 6 cells per mouse). Tumors were excised from all the mice at around 40 days after the injection, when the tumor diameter and volume were measured. The cells were applied neither stable gene transfection nor siRNAs gene knockdown assays before nude mice hepatoma formation. The cells were applied either AR agonist DHT (100 nM) for 48 h, or/and antagonist FLU (1 mM) or VPA (100 mM) for 24 h (receptor blocking) as indicated before nude mice hepatoma formation.
e Data were means7s.d. For simplification, s.ds were not shown. g -, no determination. *Po0.001, n ¼ 6, AR agonist or antagonist versus none treated; **Po0.001, n ¼ 6, gene knockdown by siRNAs versus original cell lines.
